CM
Therapeutic Areas
Sun Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ilumya (tildrakizumab) | Psoriasis | Approved |
| CEQUA (cyclosporine) | Dry Eye Disease | Approved |
| Absorica/Absorica LD | Severe Acne | Approved |
| Levulan Kerastick | Actinic Keratosis | Approved |
| Biosimilar Portfolio | Various Oncology/Autoimmune | Phase 3 |
| SCD-044 | Psoriasis | Phase 2 |
| Generic Pipeline | Multiple | Various |